Police raid striking doctors' homes, offices, after deadline passes on return-to-work order
Yoon touts improved Japan ties on Independence Movement Day as gateway to 'new world'
S. Korea, US voice 'deep concern' over NK's definition of S. Korea as 'hostile' country
S.Coups of Seventeen gets military exemption due to knee injury
Korean stocks benefit from Zuckerberg's Seoul visit
DP leader Lee retains ticket to his constituency for April elections
[Editorial] A country for children
Vote on bill to probe first lady lays bare Democratic Party split
Address by President Yoon Suk Yeol on the 105th March 1st Independence Movement Day
NewJeans, Silica Gel win 3 prizes at KMAs; Beenzino nets album of the year
Celltrion seeks approval for Stelara biosimilar in EUBy Shim Woo-hyun
Published : May 26, 2023 - 16:16
Celltrion said Friday that the company has submitted a marketing authorization application for CT-P43, the company's ustekinumab biosimilar referencing Stelara, to the European Medicines Agency.
Stelara is one of Janssen's top-selling drugs. In 2022, Stelara generated $9.7 billion in revenue, according to a report released by Statista.
The global market for ustekinumab last year was estimated at $17.7 billion, Celltrion added.
Celltrion said its CT-P43, like the reference drug Stelara, can be used to treat patients with psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis.
Celltrion added it is seeking EMA approval for the same indications that have been labeled for Stelara.
Previously, Celltrion conducted a global phase 3 clinical trial to compare the efficacy and safety of CT-P43 to Stelara in patients with moderate to severe plaque psoriasis.
If it wins approval, Celltrion will look to boost its sales.
"If CT-P43 wins the EMA approval, the company will be able to increase competitiveness in the autoimmune disease therapeutics market, where the company has previously launched treatments such as Remsima, Remsima SC and Yuflyma," Celltrion said
Opposition leader retains ticket to his constituency
Car camping: How solo female campers enjoy outdoors
Tensions loom as doctors plan mass rally in deepening clash over med school quota